Feature Channels: Vaccines

Filters close
Newswise: Flu shots are recommended for those 65 and older as cases rise
Released: 1-Dec-2022 9:05 AM EST
Flu shots are recommended for those 65 and older as cases rise
UT Southwestern Medical Center

With flu cases on the rise, geriatric specialists at UT Southwestern Medical Center say vaccinations are particularly important this year for people 65 and older who are more at risk from complications than other age groups.

Released: 30-Nov-2022 12:40 PM EST
Clover’s vaccine candidate reduced household transmission of SARS-CoV-2 in study
International Vaccine Institute

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo

Newswise: COVID-19 vaccine’s effectiveness diminishes with age, research shows
Released: 29-Nov-2022 4:00 PM EST
COVID-19 vaccine’s effectiveness diminishes with age, research shows
UT Southwestern Medical Center

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.

Released: 29-Nov-2022 1:10 PM EST
Young people make up greater proportion of COVID-19 deaths in 2021 compared to 2020
Brigham and Women’s Hospital

Since March 2020, COVID-19-related deaths claimed over a million lives in the U.S. alone.

Released: 29-Nov-2022 8:05 AM EST
Jurata Thin Film Raises $5 Million Seed Round
Jurata Thin Film

Jurata Thin Film, a startup focused on stabilizing vaccines at ambient temperature has raised initial investment funds totaling $4.87 million to develop the technology.

Released: 28-Nov-2022 12:55 PM EST
Community pharmacy-led vaccination scheme helped thousands of patients overcome hesitancy around Covid-19 jabs, research finds
Kingston University

An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by an expert from Kingston University has shown.

Newswise: Dr. Fauci reflects on the perpetual challenge of infectious diseases
Released: 28-Nov-2022 12:20 PM EST
Dr. Fauci reflects on the perpetual challenge of infectious diseases
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in The New England Journal of Medicine.

Newswise: Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
Released: 23-Nov-2022 2:00 PM EST
Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
University of Bristol

Researchers of the University of Bristol-led study, published in Science Advances today [23 November], say their findings could lead to the development of a pan-coronavirus treatment to defeat all coronaviruses.

Released: 22-Nov-2022 7:30 PM EST
Shingles associated with increased risk for stroke, heart attack
Brigham and Women’s Hospital

A new study by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, demonstrated that shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of a major cardiovascular event such a stroke or heart attack.

Released: 22-Nov-2022 2:35 PM EST
A growing trend of antibody evasion by new omicron subvariants
Ohio State University

Three currently circulating omicron subvariants of SARS-CoV-2 – including two that currently make up almost 50% of reported COVID-19 infections in the U.S. – are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, new research suggests.

21-Nov-2022 10:05 AM EST
COVID-19 vaccine gives substantial protection against reinfection
PLOS

Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup Nielsen at Statens Serum Institut, Denmark, reports these findings November 22nd in the open access journal PLOS Medicine.

21-Nov-2022 11:05 AM EST
Nation’s Health Care Organizations Urge COVID-19 and Influenza Vaccination and Treatment
American College of Physicians (ACP)

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America’s healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

Released: 21-Nov-2022 11:35 AM EST
Study finds that risk of myocarditis after SARS-CoV-2 vaccination is increased but very low
Canadian Medical Association Journal

A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, especially after the second mRNA-1273 (Moderna) vaccine, suggesting that vaccine type, age and sex should be considered when vaccinating.

Newswise: National Poll: 1 in 7 parents haven’t discussed vaccines with their child’s primary care provider during pandemic period
17-Nov-2022 8:20 AM EST
National Poll: 1 in 7 parents haven’t discussed vaccines with their child’s primary care provider during pandemic period
Michigan Medicine - University of Michigan

Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests.

Released: 18-Nov-2022 11:05 AM EST
Rutgers Scientists Produce “DNA Virus Vaccine” to Fight DNA Viruses
Rutgers University-New Brunswick

Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development.

Released: 17-Nov-2022 1:15 PM EST
Studies provide latest ‘real world’ evidence on effectiveness of covid-19 treatments
BMJ

Two studies published by The BMJ today provide up to date evidence on the effectiveness of both currently licensed and possible covid-19 treatments under everyday (‘real world’) conditions, helping to shed more light on whether these drugs can prevent people from becoming seriously ill.



close
2.52466